Autism in Young Children with Down Syndrome
患有唐氏综合症的幼儿患有自闭症
基本信息
- 批准号:10735533
- 负责人:
- 金额:$ 127.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:1 year oldAccountingAdaptive BehaviorsAddressAgeAreaBehaviorChildClinicalCognitionCommunicationCommunitiesCongenital Heart DefectsConsensusDataData Coordinating CenterDevelopmentDiagnosisDimensionsDown SyndromeEarly DiagnosisEarly InterventionEarly identificationEligibility DeterminationEpilepsyGeneral PopulationGrowthHealthIndividualInfantile spasmsIntellectual functioning disabilityLow Birth Weight InfantMeasuresMedicalModelingMosaicismMotor SkillsOutcomePersonal SatisfactionPersonsPhenotypePopulationPremature BirthPreventiveProbabilityProspective cohortProviderQuality of lifeRecommendationRecording of previous eventsResearchResearch PersonnelResearch Project GrantsRiskRisk FactorsRisk MarkerScienceScreening procedureSleep DisordersSleep disturbancesSpecificitySymptomsTestingUnited States National Institutes of HealthWorkautism spectrum disorderautistic childrenbiomarker identificationcare costsclinical carecohortcommunity based participatory researchdesigndisorder riskearly childhoodearly onsetearly screeninggastrointestinalimprovedindexinginformation gatheringinnovationmaladaptive behaviorneurogeneticsprematurerecruitresponsescreeningservice interventionsexsocial communicationtool
项目摘要
Abstract
This project aims to advance early screening procedures for autism spectrum disorder (ASD)
in young children with Down syndrome (DS). Co-occurring ASD is a lifelong condition that
impacts quality of life, adaptation, and cost of care for individuals with DS. A lack of
systematic research on early development in young children with DS has significantly
hindered efforts to identify those at heightened risk for ASD. The current lack of early
detection means that children with DS+ASD do not benefit from developmentally informed,
anticipatory early interventions that are available to the general population of young children
with ASD. This project will identify markers of ASD risk in DS with an examination of two
areas: (1) developmental presentation during early childhood in the areas of cognition,
communication, motor skills, adaptive behavior, and other relevant developmental domains,
and (2) the presence of candidate biomedical risk conditions including premature birth and
low birth weight, infantile spasms (West syndrome), congenital heart defects, sleep
dysregulation, and gastrointestinal conditions. We will characterize developmental profiles,
biomedical conditions, and ASD symptom presentation comprehensively in a cohort of 225
young children with DS across three data waves (Wave 1: 18-21 months; Wave 2: 30-33
months; Wave 3: 42-45 months). We will then model the relationship between developmental
and biomedical factors at Waves 1 and 2 and ASD presentation at Wave 3 via mixture
modeling to identify the strongest early predictors of later ASD outcomes. Based on these
analyses, we will generate recommendations for ASD screening protocols for children with
DS ages 18 to 45 months. Findings from this study will directly address the NIH INCLUDE
objective of improving health and well-being for people with DS.
抽象的
该项目旨在推进自闭症谱系障碍 (ASD) 的早期筛查程序
患有唐氏综合症(DS)的幼儿。共存自闭症谱系障碍 (ASD) 是一种终生疾病,
影响 DS 患者的生活质量、适应能力和护理费用。缺乏
对 DS 幼儿早期发展的系统研究具有显着的意义
阻碍了识别自闭症谱系障碍高风险人群的努力。目前缺乏早期
检测意味着患有 DS+ASD 的儿童无法从发展信息中受益,
面向一般幼儿群体的预期早期干预措施
患有自闭症谱系障碍(ASD)。该项目将通过检查以下两项来识别 DS 中自闭症谱系障碍 (ASD) 风险的标记:
领域:(1)幼儿时期认知领域的发展表现,
沟通、运动技能、适应性行为和其他相关发展领域,
(2) 存在候选生物医学风险状况,包括早产和
低出生体重、婴儿痉挛症(韦斯特综合征)、先天性心脏病、睡眠
调节失调和胃肠道疾病。我们将描述发展概况,
225 人队列中的生物医学状况和自闭症谱系障碍 (ASD) 症状表现
跨越三个数据波的 DS 幼儿(第 1 波:18-21 个月;第 2 波:30-33 个月)
月;第 3 波:42-45 个月)。然后我们将模拟发展之间的关系
第 1 波和第 2 波的生物医学因素以及第 3 波的 ASD 表现(通过混合)
建模以确定后来 ASD 结果的最强早期预测因素。基于这些
分析后,我们将为患有自闭症谱系障碍(ASD)儿童的筛查方案提出建议
DS 年龄为 18 至 45 个月。这项研究的结果将直接涉及 NIH INCLUDE
改善 DS 患者的健康和福祉的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicole Baumer其他文献
Nicole Baumer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicole Baumer', 18)}}的其他基金
Feasibility and outcome measures for infants with Down syndrome: Advancing clinical trial readiness for a harness-based mobility intervention
唐氏综合症婴儿的可行性和结果测量:推进基于安全带的活动干预的临床试验准备
- 批准号:
10656637 - 财政年份:2023
- 资助金额:
$ 127.5万 - 项目类别:
Impact of Congenital Heart Disease Surgery on Neurodevelopment and Behavior in Children with Down Syndrome - Admin Supp
先天性心脏病手术对唐氏综合症儿童神经发育和行为的影响 - Admin Supp
- 批准号:
10409121 - 财政年份:2021
- 资助金额:
$ 127.5万 - 项目类别:
相似国自然基金
套期会计有效性的研究:实证检验及影响机制
- 批准号:72302225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
相似海外基金
An active learning framework for adaptive autism healthcare
适应性自闭症医疗保健的主动学习框架
- 批准号:
10716509 - 财政年份:2023
- 资助金额:
$ 127.5万 - 项目类别:
Neural and Computational Architecture for Complex Navigation and Subjective Self-Location
用于复杂导航和主观自定位的神经和计算架构
- 批准号:
10664227 - 财政年份:2023
- 资助金额:
$ 127.5万 - 项目类别:
Outcomes in AYA survivors of pediatric medulloblastoma.
小儿髓母细胞瘤 AYA 幸存者的结果。
- 批准号:
10459011 - 财政年份:2022
- 资助金额:
$ 127.5万 - 项目类别:
Project 3: The Virtual Human for Precision Nutrition
项目 3:精准营养虚拟人
- 批准号:
10552681 - 财政年份:2022
- 资助金额:
$ 127.5万 - 项目类别:
Project 3: The Virtual Human for Precision Nutrition
项目 3:精准营养虚拟人
- 批准号:
10386501 - 财政年份:2022
- 资助金额:
$ 127.5万 - 项目类别: